A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...
The NCERT, the apex body for preparation of syllabus and school textbooks, wants Class IX students to study 10 subjects, double of what they do now. The students of Class IX currently study two ...
When you finish the previous chapter's tasks and begin this chapter, head to your house Common Room. You'll need to spend 98 Gems in order to do this, or wait at least 7 hours before doing so. NOTE: ...
The Navodaya Vidyalaya Samiti (NVS) has issued the Jawahar Navodaya Vidyalaya Selection Test (JNVST) 2026 admit cards. The JNVST is held for Class 9 and Class 11 entrance examinations. The hall ...
The Central Board of Secondary Education (CBSE) has maintained the rationalized curriculum for the Class 9 English Language and Literature syllabus for the 2025-26 academic session. Similar to the ...
For CBSE 2026, Class 10 can take 2 additional subjects, but Class 12 limited to one Students in CBSE 2026 exams: Class 10 may opt for 2 extra subjects, Class 12 just 1 Gulf News archives Dubai: The ...
The Rawalpindi Board of Intermediate and Secondary Education has officially declared the Class 9th results for 2025, with over 250,000 students participating in the annual exams. According to the ...
The Board of Intermediate and Secondary Education (BISE) Lahore has officially released the 9th class results for 2025 on Wednesday, August 20, 2025, at 10:00 AM. The results come after thousands of ...
The Central Board of Secondary Education (CBSE) has reportedly approved a proposal to integrate open-book assessments in Class 9 from the 2026-27 academic session. The proposal was approved by the ...
The Central Board of Secondary Education (CBSE) has approved a proposal to introduce open-book assessments for Class 9 final exams from the 2026-27 academic session after a pilot study, Indian Express ...
SAN DIEGO--(BUSINESS WIRE)--Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, today announced the completion of dosing ...